CSI Market
Sign In | Register

Rvl Pharmaceuticals Plc (RVLP) Annual Balance Sheets

Annual · GAAP · USD millions
Access RVLP quarterly Balance Sheets →
Balance sheet performance over multiple periods helps investors evaluate the financial resilience of Rvl Pharmaceuticals Plc.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
(Dec 31 2021) (Dec 31 2020) (Dec 31 2019) (Dec 31 2017)
Assets
Cash & Short-term Investments0.00
Accounts receivable3.03
Inventories0.78
Discontinued Operations0.00
Other Current Assets44.54
Prepaid Expense And Other Assets Current8.62
Total Current Assets56.98
Equipment/Property/Plant Net0.00
Goodwill net55.85
Intangible Assets13.90
Tax Assets, Noncurrent0.00
Deferred, Prepaid and Other Assets, Noncurrent0.00
Discontinued operations, Noncurrent0.00
Other Assets, Noncurrent1.79
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents44.54
Operating Lease Right Of Use Asset0.51
Total Assets128.51
Liabilities
Accounts Payable, Trade, Current2.41
Accrued Liabilities, Current AC15.40
Long-term Debt, Current Maturities LO1.43
Accrued Income Taxes, Current TA0.04
Discontinued Operation, Liabilities0.00
Total Current Liabilities19.72
Long-term debt0.00
Capital Lease and Other0.00
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent AC10.07
Discontinued Operation, Noncurrent0.00
Other liabilities, Noncurrent57.62
Finance Lease Liability Current0.01
Operating Lease Liability Current0.44
Finance Lease Liability Noncurrent0.02
Operating Lease Liability Noncurrent0.09
Total Liabilities77.42
Stockholders' Equity
Common Stock Value0.99
Additional Paid In Capital Common Stock619.32
Retained Earnings / Accumulated Deficit-569.22
Accumulated Other Comprehensive Income0.00
Other Equity0.00
Common Stockholder's Equity51.09
Non-controlling interests & other0.00
Total Stockholder's Equity51.09
Liabilities & Stockholder's Equity128.51
4 historic quarters locked

Sign in to unlock the full Rvl Pharmaceuticals Plc balance sheet history.

Sign In Create Free Account

About Rvl Pharmaceuticals Plc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001558370-23-014733

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.